Skip to main content

Table 1 Distribution of classical Kaposi sarcoma (cKS) cofactors among current study subjects and among all controls in the parent study, KCC-2

From: Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

 

cKS cases

Seropositive controls

Seronegative controls

All KCC-2 controls

 

N

(%)

n

%

n

%

n

%

Sex

        

   Male

76

(64%)

72

(69%)

100

(65%)

848

(73%)

   Female

43

(36%)

33

(31%)

55

(35%)

306

(27%)

Smoking Status

        

Never

Former

Current

58

51

10

(49%)

(43%)

(8%)

42

44

19

(40%)

(42%)

(18%)

70

64

21

(45%)

(41%)

(14%)

439

519

196

(38%)

(45%)

(17%)

Diabetes

        

Yes

No

36

83

(30%)

(70%)

14

91

(13%)

(87%)

44

111

(28%)

(72%)

202

952

(18%)

(82%)

Cortisone use*†

        

Yes

No

42

77

(35%)

(65%)

18

87

(17%)

(83%)

40

113

(26%)

(73%)

293

857

(25%)

(74%)

 

mean

range

mean

range

mean

range

mean

range

Age

75

49-94

73

39-91

73

38-91

71

32-92

  1. *During the last 10 years
  2. †Percentages may equal less than 100 due to missing data